Who Owns InfuSystem Company?

InfuSystem Bundle

Get Full Bundle:

	SWOT	$15	$10
	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10

TOTAL:

ADD TO CART

Who Really Controls InfuSystem?

Understanding the ownership of a company is crucial for investors and stakeholders alike. The ownership structure of a company directly influences its strategic decisions, financial performance, and overall direction. This article provides an in-depth analysis of InfuSystem SWOT Analysis and its ownership dynamics.

Delving into the question of "Who owns InfuSystem?" is essential for anyone looking to understand the company's operations and future prospects. This examination of InfuSystem ownership will uncover the influence of major shareholders and how it has evolved since its founding. We'll explore the impact of institutional investors, individual shareholders, and the broader implications for InfuSystem and its stakeholders, providing insights into everything from the InfuSystem stock to the company's leadership team.

Determining the exact details of the initial ownership of the InfuSystem company at its inception in 1992 presents a challenge due to the limited availability of public records. The company, InfuSystem Holdings, Inc., was established in Michigan in 1992. Publicly accessible information primarily focuses on the operational history and financial performance of the company, rather than the granular details of its initial private ownership structure.

Specific data on early backers, angel investors, or family and friends who acquired stakes during the initial phase, as well as early agreements such as vesting schedules or buy-sell clauses, are not extensively documented in public disclosures. The founding team's vision for providing infusion pumps and related services was clear, but the precise distribution of control reflecting that vision at the very beginning is not a matter of public record.

Therefore, the specifics of who owned InfuSystem in its earliest days remain largely undisclosed in publicly available sources. Information regarding the founders' initial equity split and the involvement of early investors is not readily accessible through standard public channels. The company's early ownership structure is not a matter of public record.

Ownership Details

The initial ownership structure of InfuSystem is not available in public records. The company was incorporated in Michigan in 1992. Information about the founders' equity split and early investors is not readily accessible. The company's focus is on infusion pumps and related services.

• The company's ownership structure is not available in public records.
• InfuSystem was incorporated in Michigan in 1992.
• Details about the founders' equity split are not publicly accessible.
• Information on early investors is not readily available.

InfuSystem SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

The ownership structure of the InfuSystem company has changed significantly since it became a publicly traded entity. Understanding the evolution of InfuSystem ownership provides insights into the company's strategic direction and financial stability. The transition from private to public ownership has brought in a diverse group of institutional investors, each with their own investment strategies and influence on the company.

As of March 2025, the major shareholders of InfuSystem include several prominent institutional investors. These investors collectively hold a significant portion of the company's shares, shaping its governance and strategic decisions. The InfuSystem stock is influenced by the actions and investment decisions of these key stakeholders, reflecting the dynamic nature of the market.

The presence of major institutional investors, such as Vanguard and BlackRock, highlights the significance of InfuSystem investors in influencing the company's trajectory. These institutional holdings are subject to change, and updates can be tracked through SEC filings like 13F reports, which are filed quarterly. The company's market capitalization was reported as $136.91 million as of May 23, 2024. For a deeper dive into the company's past, check out the Brief History of InfuSystem.

Key Takeaways on InfuSystem Ownership

InfuSystem ownership is primarily held by institutional investors, indicating a broad base of support.

• Vanguard and BlackRock are among the top shareholders.
• Changes in ownership can be tracked through SEC filings.
• The company's governance is influenced by the collective interests of these financial entities.
• The market capitalization was $136.91 million as of May 23, 2024.

InfuSystem PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

The current Board of Directors of the InfuSystem company plays a vital role in its governance. As of May 2024, the board includes individuals such as Richard D. D'Angelo (Chairman), Carrie N. Carmichael, Barry G. Mathis, Scott Shuda, and Kimberly Stevenson. The board is responsible for overseeing the company's strategic direction, financial performance, and risk management, acting as fiduciaries for all shareholders. The composition of the board is crucial for ensuring diverse perspectives and effective oversight.

While specific details on which directors represent major shareholders or are independent are not always explicitly available in public summaries, typical corporate governance structures aim for a balance of independent directors. This balance helps ensure that the board can make decisions that are in the best interest of all shareholders. Understanding the board's composition is key to understanding the overall InfuSystem ownership structure and how the company is managed.

InfuSystem operates under a one-share-one-vote structure, which is standard for publicly traded companies. This means that each share of common stock generally entitles the holder to one vote on matters submitted to shareholders. There is no public information suggesting dual-class shares or special voting rights that would grant outsized control to specific individuals or entities. The voting power of major institutional shareholders can significantly influence decision-making, especially in board elections and other corporate proposals. For more insights into the company's business model, you can explore Revenue Streams & Business Model of InfuSystem.

Voting Power and Governance

Understanding the board of directors and voting structure is crucial for assessing InfuSystem's ownership. The board oversees strategic direction and financial performance, acting in the best interests of shareholders.

• One-share-one-vote structure ensures voting rights are proportional to share ownership.
• Major institutional shareholders can influence decisions through their voting power.
• The board's composition is key to effective oversight and diverse perspectives.
• Board members act as fiduciaries for all shareholders.

InfuSystem Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Over the past few years, several developments have influenced the ownership profile of the InfuSystem company. For the fiscal year ending December 31, 2023, the company reported net revenues of $105.8 million. This increase in revenue could attract new investors or solidify existing holdings. Despite a net loss of $0.6 million in the fourth quarter of 2023, the full-year revenue growth indicates a positive trend.

Industry trends, such as increased institutional ownership, are evident in InfuSystem's shareholder base. Firms like Vanguard and BlackRock hold significant stakes as of early 2025. This trend suggests a professionalization of ownership, with large investors influencing the company. The company's focus on expanding services, including its biomedical services segment, may attract further investor interest or lead to strategic partnerships. InfuSystem's position in the healthcare equipment and services market, particularly in oncology practices, places it within a sector that often sees consolidation and strategic investments. For more insights, check out the Growth Strategy of InfuSystem.

The InfuSystem ownership structure is influenced by its financial performance and strategic direction. The company's growth, particularly in revenue, is a key factor attracting investors. The presence of major institutional investors like Vanguard and BlackRock suggests a stable ownership base and a focus on long-term value. The company's active participation in the healthcare market and its strategic initiatives may continue to shape its ownership dynamics.

Who Owns InfuSystem?

Institutional investors like Vanguard and BlackRock hold major stakes in the company. These large investment firms influence the company's direction.

InfuSystem Financial Performance

InfuSystem reported $105.8 million in revenue for 2023. Despite a net loss in Q4 2023, the full-year revenue increased.

InfuSystem Stock Trends

The InfuSystem stock is publicly traded. Check the stock symbol for current market information. The company’s performance impacts the stock price.

InfuSystem Investors

Major shareholders include institutional investors. The company’s growth strategy is key for attracting investors and influencing the InfuSystem investors.

InfuSystem Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

Related Blogs